Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a novel antisense transcript located on the opposite DNA strand to the gene encoding estrogen-related receptor gamma (ESRRG). Such antisense transcripts are generally classified as non-coding RNAs, and while some can modulate the expression of adjacent or overlapping genes, there is no published evidence linking this particular transcript to distinct molecular functions, disease roles, or drug interactions. It is not recognized as a receptor, enzyme, or other canonical therapeutic target. The related protein-coding gene ESRRG encodes a nuclear hormone receptor implicated in metabolic regulation, endocrine signaling, and certain diseases, but this information does not apply to the antisense transcript itself[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to estrogen-related receptor gamma.